University of Ioannina
Ανίχνευση αντισωμάτων έναντι του ιού της ηπατίτιδας C σε πολυμεταγγιζόμενα άτομα
Abstract
dc:descriptionINTRODUCTION. The purpose of this study looks into the infection of the Hepatitis C virus through the transfusion, as well as the prospects of using these results to determine the degree and the circumstances which contribute to the infection through transfusion of the Hepatitis C virus. METHODS. 270 serum samples of multitransfused individuals were examined. These samples were collected during the conduction of a research protocol before the application of compulsory tests on blood donors for the detection of anti-HCV antibodies. Determination of the antibodies was made using the ELISA method and a second generation reactor by Abbott Labs. Positive samples were further examined by carrying out supplementary tests using EIA supplementary assay and to those found positive prior to this examination the Riba 2nd generation test by Chiron and the Western blot 3rc generation by Murex were applied for verification. Results. The presence of particular antibodies to Hepatitis C virus was evident in 92 of the 141 Elisa positive samples in both methods, Riba 2nd generation and Western blot 3rd generation (65.25%), whereas 35% of the 141 samples had negative results (24.8%) and 10 (7.09%) samples were doubtful. Moreover, 4 samples were indeterminate with one of the methods and positive or negative with the other. The results of this study did not verify the 1A of the Elisa-positive samples. Evidently, it is necessary to verify all Elisa-positive samples using immunoblotting of 2nd or 3rd generation. The comparative results of the verified by both tests Elisa-positive samples presented no significant differences, which could not, therefore, justify the use of both ascertaining tests. No significant differences were observed between sexes (male 33.1%, female 36.9%). The frequency of anti-HCV antibodies increases with age at the first 5 decades of age, whereas a reduction of serum-positive individuals is evidenced at the age of 26- 40. Conclusion. Retrospecting the results of this study, we come to the conclusion that obligatory screening of blood donors for the detection of anti-HCV antibodies should be performed, even in countries that present a low Hepatitis C prevalence, based on the reliability and efficiency of 2nd and 3rd generation reactors. Yet, despite the evident improvement of the specificity and sensitivity of these reactors, it is still essential to confirm Elisa-positive samples.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2002
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Deska, Eleftheria
- Δέσκα, Ελευθερία
Subjects
dc:subject × 12Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21104